Sign In
Buy BIO
$301.90
-2.46 (-0.81%)
At Close: Jul 20, 2026
JUPITER, Fla. and WAGENINGEN, Netherlands, Dec. 01, 2025 (GLOBE NEWSWIRE) -- Dyadic Applied BioSolutions (“Dyadic”), a global biotechnology company producing precision-engineered, animal-free prot
Artisan Partners Limited Partnership Sells 1,670 Shares of Bio-Rad Laboratories, Inc. $BIO
03:56am, Saturday, 22'nd Nov 2025
Artisan Partners Limited Partnership cut its holdings in Bio-Rad Laboratories, Inc. (NYSE: BIO) by 1.4% in the undefined quarter, according to the company in its most recent filing with the Securities
Digital Identity & Biometric Access Management Provider BIO-key (Nasdaq:BKYI) Reports Q3 Results; Enhanced Post Quarter Balance Sheet Supports 2026 Growth.
BIO-key (BKYI) Partners with VaporVM to Expand Reach of Advanced Identity & Access Management and Biometric Cybersecurity Solutions in Middle East, Africa.
BIO-key Showcases Biometric Identity Innovations at Africa Tech Festival 2025, November 10-13
04:01am, Monday, 10'th Nov 2025
BIO-key (Nasdaq: BKYI) Showcases Biometric Identity Innovations at Africa Tech Festival 2025, November 10-13 at the Cape Town Convention Centre, Booth H72.
Digital Identity and Biometric Solutions Provider BIO-key Hosts Q3 Investor Call Friday, November 14th at 10am ET
02:25pm, Friday, 07'th Nov 2025
Digital Identity and Biometric Solutions Provider BIO-key (Nasdaq: BKYI) Hosts Q3 Investor Call Friday, November 14th at 10am ET. Dial-in: 1-877-418-5460.
BIO-key Secures Significant Identity and Biometric Security Deployment with a Major Middle East Defense Sector Organisation
04:00am, Friday, 07'th Nov 2025
HOLMDEL, N.J. and RIYADH, Saudi Arabia, Nov. 07, 2025 (GLOBE NEWSWIRE) -- BIO-key International, Inc. (NASDAQ: BKYI), a global leader in Identity and Access Management (IAM) and biometric authenticati
BIO-TECHNE DECLARES DIVIDEND
06:30am, Wednesday, 05'th Nov 2025
MINNEAPOLIS , Nov. 5, 2025 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) announced that its Board of Directors has decided to pay a dividend of $0.08 per share for the quarter ended September
Why Bio-Rad Laboratories Stock Slipped by More Than 3% on Thursday
05:17pm, Thursday, 30'th Oct 2025
The market didn't react positively to the diagnostics specialist's third-quarter earnings report. It beat on both the top and bottom lines, but growth rates were low.
Bio-Rad's Q3 Earnings Miss Estimates, Revenues Surpass, Stock Falls
10:06am, Thursday, 30'th Oct 2025
BIO's Q3 earnings fall short of estimates despite higher revenues, as margin pressure and weak research demand weigh on results.
Bio-Rad Laboratories, Inc. (BIO) Q3 2025 Earnings Call Transcript
07:56pm, Wednesday, 29'th Oct 2025
Bio-Rad Laboratories, Inc. ( BIO ) Q3 2025 Earnings Call October 29, 2025 5:00 PM EDT Company Participants Yong Chung - Vice President of Investor Relations Jonathan DiVincenzo - President & COO Roop
Bio-Rad Laboratories (BIO) Q3 Earnings Miss Estimates
06:56pm, Wednesday, 29'th Oct 2025
Bio-Rad Laboratories (BIO) came out with quarterly earnings of $2.26 per share, missing the Zacks Consensus Estimate of $2.3 per share. This compares to earnings of $2.01 per share a year ago.
Bio-Rad Reports Third-Quarter 2025 Financial Results
04:15pm, Wednesday, 29'th Oct 2025
HERCULES, Calif.--(BUSINESS WIRE)--Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostics products, today announced financial results for t
Tiziana Life Sciences to Present at BIO-Europe in Vienna, Highlighting Innovative Immunomodulation Therapy
07:00am, Wednesday, 29'th Oct 2025
BOSTON, Oct. 29, 2025 (GLOBE NEWSWIRE) -- Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company developing breakthrough immunomodulation therapies wi
Tonix Pharmaceuticals Announces Presentation at BIO-Europe 2025
07:00am, Tuesday, 28'th Oct 2025
CHATHAM, N.J., Oct. 28, 2025 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (“Tonix” or the “Company”), a fully-integrated commercial biopharmaceutical company announce
